Peptide Medix product catalog

Peptide Medix

CJC-1295 (No DAC) + GHRP-6

Mod GRF (1-29) paired with the first-generation hexapeptide secretagogue GHRP-6

Review catalog details Secure payments
Available to order
$85.00 $100.00 15% OFF
1
Categories: cjc-1295 ghrp-6 , growth hormone blends , ghrp peptides

Choose your delivery method

Standard Shipping is automatically selected at checkout. Customers can upgrade to a faster delivery option anytime.

Overview

This blend combines CJC-1295 without DAC — the DPP-4-resistant 29-residue GHRH analogue also catalogued as Modified GRF (1-29) — with GHRP-6, the hexapeptide that founded the entire growth hormone-releasing peptide class. GHRP-6 was derived in the 1980s from met-enkephalin analogues, years before ghrelin itself was identified, and its characterisation is what led researchers to the receptor now known as the growth hormone secretagogue receptor. Ghrelin was subsequently discovered as its endogenous ligand.

GHRP-6 is not a selective compound, and that is precisely why it remains in use. Alongside growth hormone release it produces a pronounced appetite response through central ghrelin-receptor activation, and it has measurable effects on cortisol and prolactin at higher exposures. Researchers studying feeding behaviour, orexigenic signalling or the broader pharmacology of the receptor often prefer it over the cleaner second-generation peptides for exactly that reason.

Specifications

Brand Peptide Medix
Category Growth Hormone Blends
Form Co-lyophilized powder, sealed glass vial
Purity ≥99% by HPLC per component; lot-matched COA available
Available sizes 10 mg (5 mg/5 mg)
Blend ratio 1:1 CJC-1295 (No DAC) to GHRP-6
CAS number CJC-1295 (No DAC): 863288-34-0 · GHRP-6: 87616-84-0
Molecular formula CJC-1295 (No DAC): C152H252N44O42 · GHRP-6: C46H56N12O6
Molecular weight CJC-1295 (No DAC): 3367.93 g/mol · GHRP-6: 873.01 g/mol
CJC-1295 sequence Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
GHRP-6 sequence His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
Peptide class GHRH analogue combined with a first-generation growth hormone-releasing hexapeptide
Research areas Pulsatile GH release, orexigenic and feeding-behaviour models, GHS-receptor pharmacology, cardiac tissue models
Storage Lyophilized: −20 °C, protected from light and moisture. Reconstituted: 2–8 °C, use within the study window.
Solubility Bacteriostatic water
SKU CJC-1295-GHRP-6-10-MG-5-5

Highlights

  • Co-lyophilized 1:1 blend — 5 mg CJC-1295 (No DAC) and 5 mg GHRP-6 in one sealed vial
  • ≥99% purity by third-party HPLC per component, with a lot-matched certificate of analysis
  • GHRP-6 is the original growth hormone-releasing hexapeptide and the compound that led to the ghrelin receptor
  • Marked orexigenic activity makes it the GHRP of choice in feeding-behaviour research
  • CJC-1295 (No DAC) is a DPP-4-resistant GHRH analogue, also known as Mod GRF (1-29)
  • Two distinct receptors engaged on the same pituitary cell
  • Sealed vacuum-dried vial shipped from a US facility; no diluent included

What's Included

  • The vial option and size selected above
  • Final item and quantity confirmed in cart
  • Laboratory-research-use labeling

Research Overview

GHRP-6 as the founding secretagogue

GHRP-6 emerged from work by Bowers and colleagues on met-enkephalin derivatives that released growth hormone without acting through the GHRH receptor. That observation implied an unrecognised receptor, and the search for its natural ligand ended with the isolation of ghrelin from stomach tissue in 1999. GHRP-6 is therefore not merely one secretagogue among many — it is the tool compound that opened the field, and much of the receptor's early pharmacology was mapped with it.

The orexigenic signal

Central ghrelin-receptor activation drives food intake, and GHRP-6 reproduces this robustly in rodent models. Where a study's endpoint concerns appetite regulation, hypothalamic NPY/AgRP signalling or energy homeostasis, GHRP-6's lack of selectivity is the point. Investigators who need growth hormone release without that confound generally choose Ipamorelin instead.

Why it is paired with a GHRH analogue

  • The two peptides act at separate receptors expressed on the same somatotroph.
  • GHS-receptor agonism suppresses somatostatin tone, raising the ceiling on the GHRH response.
  • Co-administration has been reported to yield a larger measured growth hormone pulse than either compound alone in animal and pituitary-cell models.
  • Both are short-acting, so the combined stimulus stays pulsatile rather than continuous.

Interpreting the evidence

Handling & Storage

Let the sealed vial reach room temperature before opening so that moisture does not condense onto the cake. Add bacteriostatic water slowly down the inner glass wall and swirl gently until the solution runs clear; avoid shaking, which shears peptide chains and creates foam that makes accurate withdrawal difficult. GHRP-6 dissolves readily, while the longer GHRH analogue may need a little more time — allow it rather than agitating. Record the concentration of each component separately, since the vial contains a fixed 1:1 mixture. Store unopened vials at −20 °C protected from light, hold reconstituted material at 2–8 °C, and label all stocks for laboratory research use only.

CJC-1295 (No DAC) + GHRP-6 FAQ

How does GHRP-6 differ from GHRP-2 and Ipamorelin?
All three act at the growth hormone secretagogue receptor but differ in selectivity. GHRP-6 is the original and least selective, with strong appetite stimulation and measurable cortisol and prolactin effects. GHRP-2 is more potent with less appetite response, and Ipamorelin is the most selective of the three.
What is CJC-1295 (No DAC)?
It is a 29-residue GHRH analogue with four amino-acid substitutions that resist DPP-4 cleavage, commonly catalogued as Modified GRF (1-29). Without the Drug Affinity Complex group it does not bind albumin, so it acts briefly and produces a discrete pulse rather than sustained elevation.
Is each component tested separately?
Yes. Purity is confirmed by HPLC and identity by mass spectrometry for each peptide at an independent laboratory before co-lyophilization. The certificate of analysis is matched to the lot number on your vial and available on request at any point.
How should the vial be stored?
Keep the sealed lyophilized vial at −20 °C, protected from light and moisture, where it remains stable long-term. Once reconstituted, hold it at 2–8 °C and use within your study window, avoiding repeated freeze–thaw cycles and prolonged periods at room temperature.

This catalog listing is for laboratory research use only. It is not represented as a drug, food, supplement, cosmetic or diagnostic product, and it is not offered for human or veterinary use.

Customer Reviews

0 reviews
5 star
0%
4 star
0%
3 star
0%
2 star
0%
1 star
0%

Leave Your Review

Rating

No reviews yet — be the first!

Leave Your Review

Rating

Keep exploring

Related Products & Shopping Guides

Compare CJC-1295 (No DAC) + GHRP-6 with relevant categories, product topics, and practical shopping information.

Often researched together

Related research peptides, blends and lab supplies frequently ordered with CJC-1295 (No DAC) + GHRP-6.

15% OFF
GHRP-6

Peptide Medix

GHRP-6

ghrp-6

2 options

$42.00 $50.00

View options and product details

15% OFF
Ipamorelin + GHRP-2

Peptide Medix

Ipamorelin + GHRP-2

ipamorelin ghrp-2
$85.00 $100.00

View options and product details